Reduces intestinal concentrations of nicotine, which activates AMPKα1 phosphorylation, which binds to SMPD3, which mediates ceramide synthesis and exacerbates NASH progression [46]. The gene discussed is SMPD3; the disease is metabolic dysfunction-associated steatohepatitis.